Kiora Pharmaceuticals (KPRX) Accumulated Expenses (2014 - 2026)
Kiora Pharmaceuticals' Accumulated Expenses came in at $1.98 million for Q2 2026, down 22.0% from $2.54 million a year earlier and down 2.2% from the prior quarter.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Kiora Pharmaceuticals' Accumulated Expenses was $2.41 million, down 47.6% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $4.59 million in FY2024 (+232.4%), $1.38 million in FY2023 (-24.8%), $1.84 million in FY2022 (+38.0%) and $1.33 million in FY2021 (+3.2%).
- The Q2 2026 figure represents the lowest quarterly Accumulated Expenses since Q3 2024.
- Year-over-year, Accumulated Expenses has declined for three consecutive quarters, with growth averaging 55.0% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2024 (growth of 232.4%), and the weakest in Q4 2025 (a decline of 47.6%).
- Business Quant data shows KPRX's Accumulated Expenses at $2.03 million (Q1 2026), $2.41 million (Q4 2025) and $2.15 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiora Pharmaceuticals | 15.81 Mn | 15.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.39 Mn |
API Access
Kiora Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "KPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();